Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
5.42
-0.03 (-0.55%)
At close: May 15, 2026, 4:00 PM EDT
5.44
+0.02 (0.37%)
After-hours: May 15, 2026, 7:21 PM EDT
Bausch Health Companies Revenue
Bausch Health Companies had revenue of $2.52B in the quarter ending March 31, 2026, with 11.73% growth. This brings the company's revenue in the last twelve months to $11.88B, up 30.90% year-over-year. In the year 2025, Bausch Health Companies had annual revenue of $10.27B with 6.66% growth.
Revenue (ttm)
$11.88B
Revenue Growth
+30.90%
P/S Ratio
0.19
Revenue / Employee
$518,768
Employees
20,300
Market Cap
2.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.27B | 641.00M | 6.66% |
| Dec 31, 2024 | 9.63B | 868.00M | 9.91% |
| Dec 31, 2023 | 8.76B | 633.00M | 7.79% |
| Dec 31, 2022 | 8.12B | -310.00M | -3.68% |
| Dec 31, 2021 | 8.43B | 407.00M | 5.07% |
| Dec 31, 2020 | 8.03B | -574.00M | -6.67% |
| Dec 31, 2019 | 8.60B | 221.00M | 2.64% |
| Dec 31, 2018 | 8.38B | -344.00M | -3.94% |
| Dec 31, 2017 | 8.72B | -950.00M | -9.82% |
| Dec 31, 2016 | 9.67B | -773.00M | -7.40% |
| Dec 31, 2015 | 10.45B | 2.24B | 27.31% |
| Dec 31, 2014 | 8.21B | 2.44B | 42.23% |
| Dec 31, 2013 | 5.77B | 2.29B | 65.77% |
| Dec 31, 2012 | 3.48B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Perrigo Company | 4.18B |
| Phibro Animal Health | 1.50B |
| Prestige Consumer Healthcare | 1.09B |
| ANI Pharmaceuticals | 923.71M |
| BioCryst Pharmaceuticals | 885.72M |
| Collegium Pharmaceutical | 796.33M |
| Supernus Pharmaceuticals | 776.83M |
| HUTCHMED (China) | 548.51M |
BHC News
- 4 days ago - Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference - PRNewsWire
- 4 days ago - Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference - PRNewsWire
- 10 days ago - Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe - Business Wire
- 17 days ago - Bausch Health Companies Earnings Call Transcript: Q1 2026 - Transcripts
- 17 days ago - Bausch Health reports Q1 non-GAAP EPS 78c, consensus 69c - TheFly
- 17 days ago - Bausch Health sees 2026 revenue $10.67B-$10.92B, consensus $10.68B - TheFly
- 17 days ago - BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS - PRNewsWire
- 24 days ago - Bausch + Lomb Announces Published Review Examining the Role of B Vitamins in Reducing Risk and Progression of Age-Related Macular Degeneration - Business Wire